Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Post-therapeutic surveillance schedule for oral cancer: is there agreement?

Liu G, Dierks EJ, Bell RB, Bui TG, Potter BE.

Oral Maxillofac Surg. 2012 Dec;16(4):327-40. doi: 10.1007/s10006-012-0356-3. Epub 2012 Sep 2. Review.

PMID:
22941063
2.

Outpatient follow-up appointments for patients having curative treatment for cancer of the head and neck: are the current arrangements in need of change?

Kanatas A, Bala N, Lowe D, Rogers SN.

Br J Oral Maxillofac Surg. 2014 Oct;52(8):681-7. doi: 10.1016/j.bjoms.2014.06.017. Epub 2014 Jul 15.

PMID:
25037165
4.

Prospective evaluation of outcome after transoral CO(2) laser resection of T1/T2 oral squamous cell carcinoma.

Jerjes W, Upile T, Hamdoon Z, Mosse CA, Akram S, Hopper C.

Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2011 Aug;112(2):180-7. doi: 10.1016/j.tripleo.2010.09.078. Epub 2011 Jan 12.

PMID:
21232996
5.

Sites of recurrence in oral and oropharyngeal cancers according to the treatment approach.

Carvalho AL, Magrin J, Kowalski LP.

Oral Dis. 2003 May;9(3):112-8.

PMID:
12945592
6.

An analysis of factors influencing the outcome of postoperative irradiation for squamous cell carcinoma of the oral cavity.

Parsons JT, Mendenhall WM, Stringer SP, Cassisi NJ, Million RR.

Int J Radiat Oncol Biol Phys. 1997 Aug 1;39(1):137-48.

PMID:
9300748
7.

A phase 2 trial of surgery with perioperative INGN 201 (Ad5CMV-p53) gene therapy followed by chemoradiotherapy for advanced, resectable squamous cell carcinoma of the oral cavity, oropharynx, hypopharynx, and larynx: report of the Southwest Oncology Group.

Yoo GH, Moon J, Leblanc M, Lonardo F, Urba S, Kim H, Hanna E, Tsue T, Valentino J, Ensley J, Wolf G.

Arch Otolaryngol Head Neck Surg. 2009 Sep;135(9):869-74. doi: 10.1001/archoto.2009.122.

8.

Clinicopathological parameters, recurrence, locoregional and distant metastasis in 115 T1-T2 oral squamous cell carcinoma patients.

Jerjes W, Upile T, Petrie A, Riskalla A, Hamdoon Z, Vourvachis M, Karavidas K, Jay A, Sandison A, Thomas GJ, Kalavrezos N, Hopper C.

Head Neck Oncol. 2010 Apr 20;2:9. doi: 10.1186/1758-3284-2-9.

9.

Analysis of death certification in patients with early stage oral cavity squamous cell carcinoma.

Kademani D, Baltali E, Lewis J, Keller E.

J Oral Maxillofac Surg. 2007 Jun;65(6):1191-7. Erratum in: J Oral Maxillofac Surg. 2007 Aug;65(8):1673. Baltlai, Evre [corrected to Baltali, Evre].

PMID:
17517305
10.

The role of clinical versus histopathological staging in patients with advanced oral squamous cell carcinoma treated with neoadjuvant radiochemotherapy followed by radical surgery.

Kreppel M, Dreiseidler T, Rothamel D, Eich HT, Drebber U, Zöller JE, Scheer M.

J Craniomaxillofac Surg. 2013 Jan;41(1):22-7. doi: 10.1016/j.jcms.2012.05.005. Epub 2012 Jun 23.

PMID:
22727901
11.

Effectiveness of routine follow-up of patients treated for T1-2N0 oral squamous cell carcinomas of the floor of mouth and tongue.

Merkx MA, van Gulick JJ, Marres HA, Kaanders JH, Bruaset I, Verbeek A, de Wilde PC.

Head Neck. 2006 Jan;28(1):1-7.

PMID:
16155911
12.

Transoral laser resection with staged discontinuous neck dissection for oral cavity and oropharynx squamous cell carcinoma.

Eckel HE, Volling P, Pototschnig C, Zorowka P, Thumfart W.

Laryngoscope. 1995 Jan;105(1):53-60. Review.

PMID:
7837914
13.

Outcome analyses of unusual site neck recurrence in oral cavity cancer.

Liao CT, Lin CY, Fan KH, Hsueh C, Lee LY, Wang HM, Huang SF, Chen IH, Kang CJ, Ng SH, Lin CH, Huang YC, Yen TC.

Ann Surg Oncol. 2013 Jan;20(1):257-66. doi: 10.1245/s10434-012-2580-3. Epub 2012 Aug 8.

PMID:
22872292
14.

Survival of patients with pathologic T0N+ oral and oropharyngeal cancer after neoadjuvant therapy and surgery: the minority report.

Perisanidis C, Sulzbacher I, Mittlböck M, Mitchell D, Czembirek C, Seemann R, Ewers R, Schopper C, Selzer E.

Oral Surg Oral Med Oral Pathol Oral Radiol. 2013 Mar;115(3):293-8. doi: 10.1016/j.oooo.2012.03.033. Epub 2012 Aug 30.

PMID:
22939322
15.

Surgical salvage for local and regional recurrence in oral cancer.

Ord RA, Kolokythas A, Reynolds MA.

J Oral Maxillofac Surg. 2006 Sep;64(9):1409-14.

PMID:
16916677
16.

Interventions for the treatment of oral cavity and oropharyngeal cancer: chemotherapy.

Furness S, Glenny AM, Worthington HV, Pavitt S, Oliver R, Clarkson JE, Macluskey M, Chan KK, Conway DI.

Cochrane Database Syst Rev. 2011 Apr 13;(4):CD006386. doi: 10.1002/14651858.CD006386.pub3. Review.

PMID:
21491393
17.

Cervical lymph node metastasis after local excision of early squamous cell carcinoma of the oral cavity.

Cunningham MJ, Johnson JT, Myers EN, Schramm VL Jr, Thearle PB.

Am J Surg. 1986 Oct;152(4):361-6.

PMID:
3766864
18.

Treatment of patients with clinically lymph node-negative squamous cell carcinoma of the oral cavity.

Jang WI, Wu HG, Park CI, Kim KH, Sung MW, Kim MJ, Choung PH, Lee JH, Choi JY.

Jpn J Clin Oncol. 2008 Jun;38(6):395-401. doi: 10.1093/jjco/hyn048.

19.

Treatment for T1-2 oral squamous cell carcinoma with or without perineural invasion: neck dissection and postoperative adjuvant therapy.

Tai SK, Li WY, Yang MH, Chang SY, Chu PY, Tsai TL, Wang YF, Chang PM.

Ann Surg Oncol. 2012 Jun;19(6):1995-2002. doi: 10.1245/s10434-011-2182-5. Epub 2011 Dec 28.

PMID:
22203180
20.

Preoperative radiochemotherapy and radical surgery in comparison with radical surgery alone. A prospective, multicentric, randomized DOSAK study of advanced squamous cell carcinoma of the oral cavity and the oropharynx (a 3-year follow-up).

Mohr C, Bohndorf W, Carstens J, Härle F, Hausamen JE, Hirche H, Kimmig H, Kutzner J, Mühling J, Reuther J, et al.

Int J Oral Maxillofac Surg. 1994 Jun;23(3):140-8.

PMID:
7930766
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk